CAPRICOR THERAPEUTICS, INC. (CAPR) INVESTOR ALERT Investors With Large Losses in Capricor Therapeutics, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights
Bernstein Liebhard LLP issued a shareholder-solicitation notice naming Capricor Therapeutics; no new disclosure from the company itself. The lawsuit alleges the company made false statements regarding business operations, growth prospects, and financial stability between December 17, 2025, and July 6, 2026.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.